Delivery Order SPE2DB22D3501-SPE2DB24FUZ11
Award Date 3/19/24
Potential Completion Date 3/20/24
Potential Value $2.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ANNOVERA vaginal rings. The $23,691.99 contract has a completion date of March 7, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceutical products and medical supplies to the Department of Defense through various DLA contracts,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Annovera vaginal rings. The contract has a potential value of $1,419.98 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of ANNOVERA vaginal rings. The $2,348.82 contract has a performance period through March 21, 2024. AmerisourceBergen Drug Corp is the prime contractor and has held a $999,999,999.00 indefinite delivery contract (IDC) with DLA since 2025 to deliver pharmaceutical products and medical...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,348.82 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ANNOVERA vaginal rings. This order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the prime contractor, which serves as the primary vehicle for the company to deliver pharmaceutical products and...
- The Defense Logistics Agency awarded a $914.76 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation to provide ANNOVERA vaginal rings. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location. The Defense Logistics Agency supports Department of Defense programs by procuring food, clothing, medicines, fuels, and other necessary supplies. This delivery order was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $2,958.90 firm fixed price delivery order is for Annovera vaginal rings, with a performance period through March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,506.26 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,176.93 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order totaling $1,377.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on June 2, 2025, with completion expected by June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $36,000 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide Annovera vaginal rings to the Defense Logistics Agency. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location. No major subcontractors or set aside designations were identified. The Defense Logistics...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUZ11Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Annovera vaginal rings. The $2,050.77 contract has a performance period through March 20, 2024. Amerisourcebergen is an experienced prime contractor for DLA, holding an indefinite delivery contract valued up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. No set-aside designation was used for this specific delivery order.
Generated 6/18/24, 3:16 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 3/19/24 |